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ABSTRACT 
Objective: Ketoprofen is a nonsteroidal anti-inflammatory drug which could benefit if fabricated in a sustained delivery system. This work aims to 
develop the sustained release delivery system for ketoprofen using natural polymers.  
Methods: Alginate microspheres were prepared employing crosslinking method employing calcium chloride. The formation and compatibility of 
microspheres was confirmed by FT-IR. The formed microspheres were evaluated for percentage yield, drug content, drug loading, and 
encapsulation efficiency. In vitro release studies were carried out in phosphate buffer (pH 7.4). 
Results: FT-IR spectra exhibited the successful compatible encapsulation of ketoprofen in alginate microsphers. The formed microspheres 
exhibited good drug loading and encapsulation efficiency. The drug release was sustained over a period of 8 hours. There was a better release 
profile in phosphate buffer in formulations containing 3:1 polymer to drug ratio. 
Conclusion: It was feasible to prepare alginate-based microspheres capable of sustaining ketoprofen release over an extended period of time. 
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INTRODUCTION 
Microspheres are one of the multiparticulate drug delivery systems 
that are employed for prolonged or controlled drug delivery. 
Microspheres can be defined as solid, approximately spherical 
particles ranging from 1 to 1000 μm, containing dispersed drug1. 
They could be administered orally or injected into the body due to 
their small size. Biocompatibility of the polymer forming the 
microspheres and its degradation products is essential for any 
material that will be in contact with living tissues2. Additionally, 
biodegradable polymers are preferred for drug delivery 
applications, since the need for removal of the depleted device is 
eliminated. Although the number of biodegradable polymers is large, 
only a limited number of polymers are suitable for drug delivery 
applications. Suitable candidates must not only be biodegradable but 
also fit the high prerequisites of biocompatibility, processability, and 
storage stability if it is to be useful for biomedical applications3. 
Alginates are naturally occurring substances found in brown algae 
which have received considerable attention as a vehicle for 
controlled drug delivery. Alginates are block polymers which mainly 
consist of mannuronic acid (M), guluronic acid (G) and mannuronic-
guluronic (MG) blocks. Alginate is known to be nontoxic when taken 
orally and has a protective effect on the mucous membranes of the 
upper gastrointestinal tract4. Oral nonsteroidal anti-inflammatory 
drugs (NSAIDs) cause gastrointestinal disturbances at a high 
incidence, which is an obstacle in increasing doses to obtain 
sufficient therapeutic effect. Ketoprofen is a propionic acid 
derivative NSAID and is used in an anti-inflammatory and analgesic 
drug for the treatments of rheumatoid arthritis and osteoarthritis5. 
Ketoprofen exhibits poor tolerability profile. Some common adverse 
effects are gastrointestinal tract complaints such as nausea, vomiting 
and epigastric discomfort6. 
The aim of this work is to formulate and characterize alginate 
microspheres for the sustained delivery of a model drug, ketoprofen. 
MATERIALS AND METHODS 
Materials  
Ketoprofen was purchased from Modern Pharma (Sana’a, Yemen). 
Sodium alginate was purchased from B. M. S (Italy). All chemicals 
used were of analytical grade and were used as received. 
Preparation of microspheres 
Sodium alginate microspheres containing ketoprofen were prepared 
by cross-linking technique followed by Fattah etal7and Bert et al 
8with minor modifications. Sodium alginate was dissolved gradually 
in distilled water at different concentrations. Drug polymer solution 
was prepared by dissolving the drug slowly into previously 
prepared alginate solution with continuous and uniform stirring for 
30 minutes. A gelation medium was prepared separately by 
dissolving 5g of calcium chloride in 100 ml distilled waters. Bubble 
free dispersion medium was extruded by dropping through glass 
syringe (20G) into the gently agitated CaCl2 solution. The agitation 
was carried out by the propeller at 200rpm.  
After 1hour, 2 ml of isopropyl alcohol were added drop wise to 
harden the formed microspheres9. After 10 minutes, the 
microspheres were removed by filtration from the solution and 
washed with de-ionized water. The microspheres were dried at 45ºC 
until they attained constant weight.  
Characterization of microspheres 
FT-IR 
The IR spectrum of the drug, polymer and prepared microspheres 
were obtained to confirm the encapsulation of the drug in the 
microsphere as well as the stability of the formed microspheres. 
Measurements were performed using Perkin Elmer Spectrum 65 
(Wisconsin, MI, USA). The particles were finely grounded with KBr 
to prepare the pellets under a hydraulic pressure of 600 dynes/m2 
and spectra were scanned between 4000 to 400 cm-1. 
Percentage yield 
The dried microspheres were weighed and the percentage yield of 
the prepared microspheres was calculated by using the following 
formula. 
Percentage yield = {The weight of microspheres / The weight of 
polymer + drug}*100 
Drug content 
The various batches of the microspheres were subjected for drug 
content analysis. Accurately weighed microsphere samples were 
mechanically powdered. Powdered microspheres were dissolved in 
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adequate quantity of phosphate buffer PH 7.4 then filtered. The UV 
absorbance of the filtrate was measured using a UV spectrometer at 262 
nm[10]. 
Drug loading and encapsulation efficiency 
Drug loading and encapsulation efficiency were determined for all 
batches using the following formulas. Values are expressed as 
percentage. 
Drug loading = {Weight of drug in microspheres / Microspheres 
sample weight} * 100 
Encapsulation efficiency = {Actual weight of drug in sample/ 
Theoretical weight of drug} * 100 
In vitro drug release 
The study of the release of ketoprofen was carried using 50 ml of 
phosphate buffer pH 7.4 as a dissolution medium. 20 mg equivalent 
ketoprofen containing alginate microspheres was maintained at 
37oC±0.5oC. Five millilitres of sample were withdrawn at specific 
time interval for 8 hours. The sample volume was replaced by an 
equal volume of fresh medium. The concentration was determined 
spectrophotometrically at 262 nm.  
 
Table 1: Composition of alginate microspheres 
Formulation Alginate content (g) Drug content (g) 
F1 4.5 3 
F2 4.5 1.5 
F3 3 3 
F4 3 1.5 
RESULTS AND DISCUSSION 
Four different formulations were prepared varying in polymer and 
drug concentrations (Table 1). The drug to polymer ratio of the 
different formulations was 2:3, 1:3, 1:1, and 1:2. 
The entrapment and stability of ketoprofen in the alginate 
microspheres were investigated by infrared spectroscopy study (IR). 
Fig. 1 represents the IR spectra of ketoprofen, alginate, and formed 
microspheres. Ketoprofen spectrum shows absorption bands for C=O 
stretching vibration of acid, C=O stretching vibration of ketone, O-H 
band and C=C stretching vibration of the aromatic ring appeared at 
1697, 1655, 3380, and 3100 cm-1, respectively.  
IR spectrum of alginate showed intense absorption bands at 1796 cm-
1and 1874 cm-1 due to C=O vibrations of an acid group. Multiple bands 
in the range of 3400-3600 cm-1can be attributed to O-H alcohol and 
acid. The IR spectrum of the alginate microspheres encapsulating 
ketoprofen showed the broad bands in the 3658, 3620, 3413 cm-
1range, which are attributed to the stretching vibration of O-H group of 
ketoprofen and alginate compounds.  
The distinctive peak which appeared at 3100 cm-1was assigned for the 
C=C aromatic group of ketoprofen. Also a strong intensity band was 
observed at 1658 cm-1due to C=O ketone of ketoprofen. Similarly, the 
C=O acids of ketoprofen and alginate were observed at 1795 cm-1and 
1886 cm-1.  
Thus, the IR study indicates the stable nature of ketoprofen in the 
prepared alginate microspheres. IR spectra of the microspheres indicate 
that there is no strong interaction between the drug and the polymers. 
Hence, drug excipients compatibility was established which indicates the 
stable nature of the drug during the entrapment process. 
 
 
Fig. 1: IR spectra of ketoprofen (upper), alginate (middle), and ketoprofen-loaded microspheres (lower) 
 
The percentage yield of formulations was found out to be 71.40%, 
87.51%, 77.24%, and 75.58% for formulations F1-F4 respectively 
(Table2). Higher drug content (and hence, percentage yield) was 
observed in formulations containing 3g alginate polymer and 3 g 
ketoprofen (formulation containing 1:1 drug to polymer ratio). A 
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concentration of surfactant, stirring rate of the emulsion and 
average size of microspheres could affect drug loading[11]. They 
found that drug loading could be increased by increasing drug to 
albumin ratio, decreasing surfactant concentration and increasing 
the stirring rate.  The results of the variation in drug loading and 
encapsulation efficiency with polymer: ketoprofen ratio are shown 
in table 3. Higher percentage of loading was obtained by increasing 
the amount of the drug with respect to alginate. Formulations 
exhibited good encapsulation efficiencies between the range of 
70.88% to 96.12% depending on the composition of the different 
microspheres. The high percentage yields obtained in our study 
indicates that this method was very useful for adoption in the 
formulation of ketoprofen microspheres. Higher percentage yield 
was observed for formulations containing higher drug to polymer 
ratio. These findings comply well with results reported in other 
studies [12]. 
 
Table 2: Drug content and percentage yield of microspheres. 
Formulation Percentage yield (%) Drug content (G) 
F1 71.40 1.774 
F2 87.51 1.005 
F3 77.24 2.68 
F4 75.58 1.017 
 
Table 3: Drug loading and encapsulation efficiency of microspheres 
Formulation Drug loading (%) Encapsulation efficiency (%) 
F1 33.12 74.31 
F2 19.11 70.88 
F3 59.98 96.12 
F4 32.55 85.32 
 
In vitro drug release studies were carried out employing phosphate 
buffer (pH 7.4). Fig. 2 and 3 show the cumulative release of 
ketoprofen from alginate microspheres in phosphate buffer. The 
drug release was prolonged for up to 8 hours in all formulations. 
Formulation F2 with 3:1 polymer to drug ratio showed lowest burst 
release. 
 
Fig. 2: In vitro release of ketoprofen in phosphate buffer from 
formulations F1 and F2. (n=4) 
 
 
Fig. 3: In vitro release of ketoprofen in phosphate buffer from 
formulations F3 and F4. (n=4) 
 
The release of ketoprofen from the alginate microspheres could be 
attributed to diffusion and/or erosion. The drug could diffuse out of 
the alginate microspheres. Secondly, the drug can be released from 
the alginate microspheres through the erosion of the matrix. The 
erosionis due to the removal of the cross-linker bivalent cation, 
calcium, from the alginate microspheres [13]. Even if the 
microspheres did not burst, large swelling occurred and thus 
increased matrix porosity. These findings comply well with the 
higher drug to polymer ratio used in formulation F1 [14].  
The disruption of the alginate matrix occurred fast in a phosphate 
buffer because of the chelating action of phosphate ions and at pH 
7.4, the affinity to phosphate was higher than that to alginate, and 
consequently, the drug was released from alginate microspheres 
through the continuous erosion of the microspheres. Both of our 
formulations exhibited a sustained release of risperidone over a 
period of 8 hours. A slower release pattern was observed for 
formulation containing higher amounts of the polymer. Kilicarsan 
and Baykara investigated the effect of the drug/polymer ratio on 
properties of the verapamil loaded microspheres [15].  
They found that the drug release profile could be sustained by 
increasing polymer amount. Similarly, insulin and 
diaminopyridinemicroparticles were prepared by solvent 
evaporation method and drug/polymer ratio was shown to affect 
microspheres characteristics and drug release [16,17]. The initial 
burst release could be related to the surface drug as well as small 
size microspheres which might be due to the fact that smaller 
particles offered more surface area to release the drug. A similar 
release pattern has been reported elsewhere in which about 50% of 
the loaded drug released within 1 h, which was attributed to the 
amount of drug adsorbed on the surface of microspheres[18]. 
CONCLUSION 
Alginate-based microspheres of ketoprofen were successfully 
prepared and separated by cross-linking technique. The formed 
microspheres showed good percentage yield and encapsulation 
efficiency. In vitro drug release showed prolonged release of 
ketoprofen employing phosphate buffer an as release media. Slower 
drug release was observed with increasing the polymer 
concentration. It was feasible to prepare alginate-based 
microspheres capable of sustaining drug release over an extended 
period of time. Such a system has several advantages for drug 
delivery. In the case of ketoprofen, this system could reduce the GIT-
related side effects inherent to the drug. The drug delivery system 
could serve to deliver many drugs that could benefit from such 
sustained delivery. 
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